214 related articles for article (PubMed ID: 24530271)
1. Parkinson׳s disease-related modulation of functional connectivity associated with the striatum in the resting state in a nonhuman primate model.
Li J; Luo C; Chen Y; Chen Q; Huang R; Sun J; Gong Q; Wu X; Qi Z; Liang Z; Li L; Li H; Li P; Wang W; Shang HF
Brain Res; 2014 Mar; 1555():10-9. PubMed ID: 24530271
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
Chao KT; Tsao HH; Weng YH; Hsiao IT; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lin KJ
Synapse; 2012 Sep; 66(9):823-31. PubMed ID: 22623146
[TBL] [Abstract][Full Text] [Related]
3. Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.
Oiwa Y; Eberling JL; Nagy D; Pivirotto P; Emborg ME; Bankiewicz KS
Front Biosci; 2003 Sep; 8():a155-66. PubMed ID: 12957824
[TBL] [Abstract][Full Text] [Related]
4. MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.
Miletich RS; Bankiewicz KS; Quarantelli M; Plunkett RJ; Frank J; Kopin IJ; Di Chiro G
Ann Neurol; 1994 Jun; 35(6):689-97. PubMed ID: 8210225
[TBL] [Abstract][Full Text] [Related]
5. Quantitative analysis of the therapeutic effect of magnolol on MPTP-induced mouse model of Parkinson's disease using in vivo 18F-9-fluoropropyl-(+)-dihydrotetrabenazine PET imaging.
Weng CC; Chen ZA; Chao KT; Ee TW; Lin KJ; Chan MH; Hsiao IT; Yen TC; Kung MP; Hsu CH; Wey SP
PLoS One; 2017; 12(3):e0173503. PubMed ID: 28257461
[TBL] [Abstract][Full Text] [Related]
6. Nigrostriatal dopamine-independent resting-state functional networks in Parkinson's disease.
Ham JH; Cha J; Lee JJ; Baek GM; Sunwoo MK; Hong JY; Shin NY; Sohn YH; Lee JM; Lee PH
Neuroimage; 2015 Oct; 119():296-304. PubMed ID: 26143204
[TBL] [Abstract][Full Text] [Related]
7. Differential synaptic plasticity of the corticostriatal and thalamostriatal systems in an MPTP-treated monkey model of parkinsonism.
Raju DV; Ahern TH; Shah DJ; Wright TM; Standaert DG; Hall RA; Smith Y
Eur J Neurosci; 2008 Apr; 27(7):1647-58. PubMed ID: 18380666
[TBL] [Abstract][Full Text] [Related]
8. Progressive changes of pre- and post-synaptic dopaminergic biomarkers in conscious MPTP-treated cynomolgus monkeys measured by positron emission tomography.
Nagai Y; Obayashi S; Ando K; Inaji M; Maeda J; Okauchi T; Ito H; Suhara T
Synapse; 2007 Oct; 61(10):809-19. PubMed ID: 17598150
[TBL] [Abstract][Full Text] [Related]
9. Motor behavior correlates with striatal [¹⁸F]-DOPA uptake in MPTP-lesioned primates.
Kortekaas R; Eshuis SA; Andringa G; Cools AR; Leenders KL
Neurochem Int; 2013 Mar; 62(4):349-53. PubMed ID: 23357476
[TBL] [Abstract][Full Text] [Related]
10. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.
Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P
Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735
[TBL] [Abstract][Full Text] [Related]
11. Validation of nigrostriatal positron emission tomography measures: critical limits.
Karimi M; Tian L; Brown CA; Flores HP; Loftin SK; Videen TO; Moerlein SM; Perlmutter JS
Ann Neurol; 2013 Mar; 73(3):390-6. PubMed ID: 23423933
[TBL] [Abstract][Full Text] [Related]
12. Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins.
Petzinger GM; Fisher B; Hogg E; Abernathy A; Arevalo P; Nixon K; Jakowec MW
J Neurosci Res; 2006 Feb; 83(2):332-47. PubMed ID: 16385585
[TBL] [Abstract][Full Text] [Related]
13. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Abnormal Metabolic Brain Networks by Experimental Therapies in a Nonhuman Primate Model of Parkinson Disease: An Application to Human Retinal Pigment Epithelial Cell Implantation.
Peng S; Ma Y; Flores J; Cornfeldt M; Mitrovic B; Eidelberg D; Doudet DJ
J Nucl Med; 2016 Oct; 57(10):1591-1598. PubMed ID: 27056614
[TBL] [Abstract][Full Text] [Related]
15. Antiparkinsonian mechanism of electroconvulsive therapy in MPTP-lesioned non-human primates.
Landau AM; Clark C; Jivan S; Doudet DJ
Neurodegener Dis; 2012; 9(3):128-38. PubMed ID: 22327563
[TBL] [Abstract][Full Text] [Related]
16. Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study.
Blesa J; Juri C; Collantes M; Peñuelas I; Prieto E; Iglesias E; Martí-Climent J; Arbizu J; Zubieta JL; Rodríguez-Oroz MC; García-García D; Richter JA; Cavada C; Obeso JA
Neurobiol Dis; 2010 Jun; 38(3):456-63. PubMed ID: 20304066
[TBL] [Abstract][Full Text] [Related]
17. Progressive loss of striatal dopamine terminals in MPTP-induced acute parkinsonism in cynomolgus monkeys using vesicular monoamine transporter type 2 PET imaging ([(18)F]AV-133).
Liu Y; Yue F; Tang R; Tao G; Pan X; Zhu L; Kung HF; Chan P
Neurosci Bull; 2014 Jun; 30(3):409-16. PubMed ID: 24061965
[TBL] [Abstract][Full Text] [Related]
18. Increased DAT binding in the early stage of the dopaminergic lesion: a longitudinal [11C]PE2I binding study in the MPTP-monkey.
Vezoli J; Dzahini K; Costes N; Wilson CR; Fifel K; Cooper HM; Kennedy H; Procyk E
Neuroimage; 2014 Nov; 102 Pt 2():249-61. PubMed ID: 25108180
[TBL] [Abstract][Full Text] [Related]
19. Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys.
Brown CA; Campbell MC; Karimi M; Tabbal SD; Loftin SK; Tian LL; Moerlein SM; Perlmutter JS
Exp Neurol; 2012 Jul; 236(1):190-7. PubMed ID: 22579525
[TBL] [Abstract][Full Text] [Related]
20. Altered corticostriatal functional connectivity in obsessive-compulsive disorder.
Harrison BJ; Soriano-Mas C; Pujol J; Ortiz H; López-Solà M; Hernández-Ribas R; Deus J; Alonso P; Yücel M; Pantelis C; Menchon JM; Cardoner N
Arch Gen Psychiatry; 2009 Nov; 66(11):1189-200. PubMed ID: 19884607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
